Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Aug, 11 2025
Sep, 27 2025
Mar, 22 2025
Feb, 19 2026
Nov, 16 2025